GET DAILY SIGNALSVerisign (VRSN) Q3 2026: Revenue Beats Expectations but EPS Miss and Softer Cash Flow Draw Attention
Key Takeaways
- Verisign reported third quarter 2026 revenue of $443.0 million, up 5.7% year over year and modestly above consensus estimates.
- Adjusted earnings per share (EPS) of $2.41 came in slightly below the consensus estimate of $2.42, a rare miss for the company.
- GAAP net income was $212.6 million, or $2.35 per diluted share, pressured by a $7.5 million pre-tax loss on certain assets held for sale.
- The .com and .net domain name base grew to 182.5 million names (up 6.1% year over year), supported by a record 13.1 million new registrations.
- Operating cash flow declined to $268 million from $308 million, while free cash flow fell to $261 million from $303 million a year earlier.
- Management raised full-year 2026 revenue and operating income guidance and lifted its domain base growth outlook to 6.5%–7%.
Earnings Context and Why It Matters
Verisign operates critical internet infrastructure as the exclusive registry for the .com and .net top-level domains, giving its results broad read-through for digital commerce and online activity. After several quarters of accelerating domain name base growth, this report tests whether that momentum can translate into sustained profitability. Investors also watch Verisign closely for its capital allocation, as the company combines share repurchases with a quarterly dividend. A rare earnings miss, paired with softer cash generation and a one-time asset-related charge, sharpened scrutiny of near-term margins even as top-line demand remained robust. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Reported Results
Verisign posted revenue of $443.0 million for the quarter ended September 30, 2026, an increase of 5.7% from $419.1 million in the prior-year period. The result slightly exceeded analyst expectations. Adjusted earnings per share were $2.41, just below the consensus estimate of $2.42, while GAAP net income came in at $212.6 million, or $2.35 per diluted share.
Operating income rose to $296.5 million from $284.3 million a year ago, though operating expenses climbed to $147 million from $135 million. The quarter included a $7.5 million pre-tax operating loss related to certain assets held for sale, which reduced diluted EPS by roughly $0.06. The combined .com and .net domain name base reached 182.5 million names, up 6.1% year over year and up 3.4 million sequentially, driven by a record 13.1 million new registrations. The preliminary renewal rate was 74.3%, down from 75.4% a year earlier.
Cash generation softened, with operating cash flow of $268 million (versus $308 million) and free cash flow of $261 million (versus $303 million). The company ended the quarter with $476 million in cash, cash equivalents, and marketable securities, repurchased 0.7 million shares for $189 million, and declared an $0.81 per-share dividend payable November 24, 2026.
Market Reaction and Investor Sentiment
Verisign shares fell approximately 3.15% to around $295 in after-hours trading following the announcement, according to Investing.com, reflecting investor disappointment over the earnings miss and the step-down in cash generation despite record domain growth. The stock had risen roughly 26.5% year to date, outperforming the broader market, which likely raised the bar for the quarter. While strong top-line momentum and raised full-year guidance were positives, the one-time asset-related charge and lower free cash flow appeared to weigh more heavily on sentiment heading into the following session.
Forward Outlook and Key Factors to Monitor
Management raised its full-year 2026 outlook, now expecting revenue between $1.755 billion and $1.760 billion and operating income between $1.188 billion and $1.192 billion. The updated operating income range reflects the $7.5 million charge booked in the third quarter. Domain name base growth guidance was also lifted to 6.5%–7% for 2026, signaling continued confidence in demand.
Investors should watch whether record new registrations convert into durable renewal strength, particularly given the preliminary third-quarter renewal rate of 74.3%, which declined year over year. Management attributed that decline partly to a higher mix of first-time renewing names.
Two strategic initiatives merit attention. The planned launch of the .web TLD is progressing, with a sunrise period expected to begin in mid-December and general availability anticipated in 2027. Separately, Verisign introduced Verisign Informed, a security service for digital credential verification, with pricing expected to be finalized by year end and production delivery targeted for the first half of 2027. Cost trends, cash tax effects, and free cash flow recovery will also be key metrics to follow as the company balances infrastructure investment with shareholder returns. From what I see, the raised guidance provides a constructive backdrop, though execution on renewals will be important to track.
Using AI Tools in My Research Process
I often turn to Tickeron’s AI Screener when analyzing earnings reports like this one. It lets me quickly filter stocks by technical patterns, fundamentals, and industry trends to put results in context and spot comparable opportunities without spending hours on manual work. The tool has become a regular part of how I evaluate companies reporting results, especially when cash flow and guidance shifts are in focus.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Aroon Indicator for VRSN shows an upward move is likely
VRSN's Aroon Indicator triggered a bullish signal on September 28, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 257 similar instances where the Aroon Indicator showed a similar pattern. In 157 of the 257 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 61%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on VRSN as a result. In 50 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 58%.
The Moving Average Convergence Divergence (MACD) for VRSN just turned positive on October 08, 2026. Looking at past instances where VRSN's MACD turned positive, the stock continued to rise in 24 of 49 cases over the following month. The odds of a continued upward trend are 49%.
VRSN moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for VRSN crossed bullishly above the 50-day moving average on October 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +0.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where VRSN advanced for three days, in 205 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
Bearish Trend Analysis
The 10-day RSI Indicator for VRSN moved out of overbought territory on September 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 18 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 49%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VRSN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 17 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 27 (best 1 - 100 worst), indicating outstanding price growth. VRSN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 47 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.
The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-12.322) is normal, around the industry mean (15.930). P/E Ratio (33.252) is within average values for comparable stocks, (56.422). Projected Growth (PEG Ratio) (2.080) is also within normal values, averaging (3.648). Dividend Yield (0.011) settles around the average of (0.209) among similar stocks. P/S Ratio (16.129) is also within normal values, averaging (103.889).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of internet infrastructure services
Industry ComputerCommunications
Advertisement